ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
2,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
4,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
6,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
6,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
7,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
8,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
9,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
10,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
10,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
11,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
11,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
11,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11,4,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
11,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
12,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
13,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
14,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
15,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
15,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
16,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
17,1,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
17,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
17,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
17,4,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
18,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
18,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
18,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
18,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
18,5,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
18,6,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
18,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
19,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
19,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
20,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
20,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
20,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
20,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
21,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
22,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
23,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
23,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
24,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
25,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
25,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
26,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
27,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
28,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
29,1,Allodynia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
29,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
29,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
30,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
30,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
30,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
31,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
31,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
31,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
31,4,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
31,5,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
31,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
32,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
33,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,Y
34,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
35,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
35,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
35,3,Myopathy,Myopathies,Muscle disorders,Musc,N
36,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
37,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
38,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
39,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
39,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
40,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
41,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
42,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
42,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
43,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
43,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
45,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
45,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
46,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
47,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
47,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
48,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
48,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
48,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
48,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
48,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
48,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
49,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
49,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
50,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
51,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
52,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
53,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
53,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
53,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
54,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
55,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
56,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
57,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
57,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
58,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
58,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
58,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
59,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
59,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
60,1,Deafness,Hearing losses,Hearing disorders,Ear,N
60,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
60,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
61,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
61,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
61,3,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
62,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
62,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
62,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
62,4,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
62,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
63,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
63,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
63,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
63,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
64,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
64,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
64,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
65,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
65,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
66,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
66,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
67,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
67,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
68,1,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
68,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
68,3,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
69,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
69,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
69,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
70,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
71,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
72,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
73,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
73,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
73,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
74,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
74,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
75,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
75,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
76,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
76,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
77,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
77,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
77,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
78,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
78,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
78,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
78,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
78,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
78,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
79,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
79,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
80,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
80,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
80,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
81,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
82,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
82,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
83,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
84,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
85,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
86,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
87,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
88,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
88,2,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
88,3,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
88,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
88,5,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
88,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
88,7,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
89,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
89,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
89,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
89,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
89,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
90,1,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
90,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
91,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
92,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
92,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
93,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
95,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
96,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
96,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
97,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
98,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
98,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
99,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
100,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
100,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
101,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
101,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
101,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
102,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
102,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
102,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
103,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
103,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
103,3,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
103,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
103,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
103,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
104,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
104,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
104,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
105,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
105,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
106,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
106,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
107,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
107,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
107,3,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,Y
108,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
108,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
108,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
108,4,Plasmacytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
108,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
109,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
109,2,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
110,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
110,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
110,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
111,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
112,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
113,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
113,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
114,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
115,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
116,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
116,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
117,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
118,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
118,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
118,3,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
118,4,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
119,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
119,2,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
120,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
120,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
121,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
122,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
123,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
124,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
124,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
125,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
126,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
127,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
128,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
128,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
129,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
130,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
130,2,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
130,3,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
131,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
131,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
131,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
131,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
131,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
132,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
132,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
133,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
133,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
133,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
133,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
134,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
135,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
136,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
137,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
138,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
138,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
139,1,Herpes zoster disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
140,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
140,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
141,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
142,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
142,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
143,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
144,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
145,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
146,1,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
147,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
147,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
148,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
148,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
148,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
149,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
149,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
150,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
151,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
152,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
152,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
153,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
154,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
155,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
155,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
155,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
156,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
157,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
157,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
157,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
158,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
158,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
159,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
159,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
160,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
160,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
161,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
161,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
161,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
162,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
162,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
163,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
164,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
164,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
165,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
165,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
166,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
166,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
166,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
167,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
168,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
168,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
169,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
169,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
170,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
170,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
171,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
172,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
172,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
172,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
173,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
173,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
173,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
173,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
173,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
173,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
173,7,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
173,8,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
174,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
174,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
174,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
174,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
175,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
176,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
177,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
178,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
179,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
179,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
179,3,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
179,4,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
180,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
180,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
180,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
181,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
181,2,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
182,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
183,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
183,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
184,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
184,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
185,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
185,2,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
185,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
186,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
187,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
188,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
188,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
188,3,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
188,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
189,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
190,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
191,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
191,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
192,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
193,1,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
194,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
195,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
196,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
197,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
197,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
198,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
199,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
199,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
200,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
200,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
200,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
201,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
202,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
203,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
203,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
203,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
204,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
204,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
204,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
205,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
205,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
205,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
206,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
206,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
207,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
207,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
208,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
209,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
209,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
209,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
209,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
210,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
211,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
212,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
213,1,Blood osmolarity decreased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
213,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
213,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
214,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
214,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
215,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
216,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
216,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
216,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
217,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
217,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
217,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
217,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
217,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
218,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
218,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
218,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
218,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
219,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
219,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
220,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
220,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
221,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
222,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
222,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
223,1,Splenic haemorrhage,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
224,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
224,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
225,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
225,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
225,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
226,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
227,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
228,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
228,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
229,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
229,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
230,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
231,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
232,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
233,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
233,2,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
234,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
234,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
234,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
235,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
236,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
236,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
236,3,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
237,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
238,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
239,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
240,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
240,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
241,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
242,1,Bronchial wall thickening,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
242,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
243,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
244,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
244,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
244,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
244,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
245,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
246,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
247,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
248,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
248,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
249,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
250,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
251,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
252,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
253,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
253,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
253,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
253,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
253,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
253,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
253,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
254,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
255,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
256,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
257,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
257,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
257,3,Tic,Tic disorders,Changes in physical activity,Psych,N
258,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
258,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
259,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
260,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
261,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
261,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
262,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
262,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
262,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
262,4,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
262,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
262,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
263,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
264,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
264,2,Death,Death and sudden death,Fatal outcomes,Genrl,N
264,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
265,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
266,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
266,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
266,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
266,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
266,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
266,6,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
266,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
266,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
267,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
268,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
269,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
270,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
270,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
271,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
272,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
272,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
272,3,Pathological fracture,Fractures NEC,Fractures,Musc,N
273,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
273,2,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
274,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
274,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
275,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
276,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
276,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
277,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
278,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
279,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
279,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
280,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
281,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
281,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
282,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
283,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
283,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
284,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
285,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
285,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
286,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
286,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
287,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
288,1,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
289,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
289,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
289,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
290,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
290,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
291,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
292,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
293,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,Y
294,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
294,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
294,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
295,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
295,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
295,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
296,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
296,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
296,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
297,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
298,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
299,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
300,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
300,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
300,3,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
301,1,Rotator cuff syndrome,Joint related disorders NEC,Joint disorders,Musc,N
302,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
302,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
303,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
303,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
303,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
304,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
304,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
305,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
307,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
308,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
309,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
310,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
310,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
311,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
311,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
312,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
313,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
313,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
314,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
314,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
314,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
315,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
315,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
316,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
317,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
318,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
319,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
319,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
320,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
321,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
322,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
323,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
324,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
324,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
324,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
324,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
324,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
324,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
325,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
326,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
327,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
327,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
327,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
328,1,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
329,1,Deafness,Hearing losses,Hearing disorders,Ear,N
329,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
330,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
331,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
332,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
333,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
334,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
335,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
336,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
337,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
338,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
338,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
339,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
339,2,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
340,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
341,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
342,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
343,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
343,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
343,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
343,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
344,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
345,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
346,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
346,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
346,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
346,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
347,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
348,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
349,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
350,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
351,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
352,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
353,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
353,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
354,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
354,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
355,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
356,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
356,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
356,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
356,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
357,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
357,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
357,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
358,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
358,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
359,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
361,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
361,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
362,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
363,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
363,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
364,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
365,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
365,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
365,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
365,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
366,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
367,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
367,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
367,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
368,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
368,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
369,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
370,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
371,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
372,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
372,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
372,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
372,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
372,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
373,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
374,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
374,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
374,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
375,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
376,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
376,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
378,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
378,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
379,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
379,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
380,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
381,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
382,1,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
382,2,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
383,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
383,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
384,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
385,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
386,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
387,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
387,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
388,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
388,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
389,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
390,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
390,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
391,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
391,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
392,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
392,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
392,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
393,1,Headache,Headaches NEC,Headaches,Nerv,N
393,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
393,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
393,4,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
394,1,Cranial nerve paralysis,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
394,2,Headache,Headaches NEC,Headaches,Nerv,N
395,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
396,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
397,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
398,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
399,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
399,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
399,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
400,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
400,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
401,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
402,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
402,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
402,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
403,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
404,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
405,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
406,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
407,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
407,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
408,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
408,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
408,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
408,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
409,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
410,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
411,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
411,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
412,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
412,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
413,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
413,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
413,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
414,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
414,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
414,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
414,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
415,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
415,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
415,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
415,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
415,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
416,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
416,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
417,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
418,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
418,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
419,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
420,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
420,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
420,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
420,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
420,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
420,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
421,1,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
422,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
423,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
423,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
423,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
423,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
424,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
425,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
426,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
426,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
426,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
426,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
426,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
427,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
428,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
429,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
430,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
430,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
431,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
432,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
433,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
433,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
434,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
435,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
436,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
437,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
438,1,Coronary arterial stent insertion,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
439,1,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
439,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
439,3,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
440,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
440,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
441,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
442,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
443,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
443,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
444,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
444,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
444,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
445,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
446,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
447,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
448,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
448,2,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
449,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
449,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
449,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
450,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
450,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
450,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
450,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
451,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
452,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
453,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
454,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
455,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
455,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
455,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
456,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
457,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
457,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
457,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
458,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
459,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
460,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
461,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
462,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
463,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
464,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
465,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
465,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
465,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
466,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
466,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
467,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
468,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
468,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
469,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
469,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
470,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
470,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
470,3,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
471,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
472,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
473,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
474,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
474,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
475,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
476,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
477,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
478,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
478,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
478,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
479,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
479,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
479,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
479,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
480,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
480,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
481,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
481,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
482,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
482,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
482,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
483,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
483,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
483,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
483,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
483,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
484,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
484,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
484,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
485,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
485,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
486,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
486,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
487,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
487,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
488,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
489,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
489,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
490,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
491,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
491,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
491,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
492,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
493,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
494,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
495,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
496,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
496,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
496,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
496,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
496,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
497,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
497,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
497,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
497,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
497,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
497,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
497,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
498,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
499,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
499,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
499,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
500,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
500,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
500,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
501,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
501,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
502,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
503,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
504,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
504,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
505,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
506,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
506,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
507,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
507,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
507,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
507,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
508,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
508,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
509,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
510,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
510,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
510,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
510,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
510,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
511,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
512,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
513,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
514,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
515,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
516,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
517,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
518,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
519,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
520,1,Aortic stenosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,Y
521,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
521,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
521,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
521,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
522,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
522,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
522,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
522,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
523,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
523,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
523,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
523,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
524,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
525,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
526,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
527,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
528,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
528,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
529,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
529,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
530,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
531,1,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
532,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
533,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
534,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
535,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
536,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
536,2,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
536,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
537,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
537,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
537,3,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
538,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
539,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
539,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
539,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
540,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
540,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
541,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
542,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
542,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
543,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,Y
544,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
544,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
545,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
546,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
546,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
546,3,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
547,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
547,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
548,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
548,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
549,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
549,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
550,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
550,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
551,1,Sudden hearing loss,Hearing losses,Hearing disorders,Ear,N
552,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
552,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,3,Enterovesical fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
553,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
554,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
554,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
555,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
556,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
557,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
557,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
558,1,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
559,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
559,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
559,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
559,4,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
559,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
560,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
561,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
562,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
562,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
562,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
562,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
563,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
564,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
564,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
564,3,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
565,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
565,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
567,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
567,2,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
567,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
568,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
569,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
569,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
570,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
571,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
572,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
573,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
574,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
574,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
574,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
574,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
575,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
576,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
577,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
578,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
579,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
579,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
579,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
580,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
580,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
580,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
581,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
581,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
582,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
583,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
584,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
585,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
585,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
585,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
586,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
586,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
586,3,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
587,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
587,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
588,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
589,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
589,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
589,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
589,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
590,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
590,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
590,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
591,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
591,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
591,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
592,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
592,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
593,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
593,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
594,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
595,1,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
596,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
596,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
597,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
598,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
598,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
599,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
599,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
600,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
600,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
600,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
601,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
602,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
603,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
604,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
605,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
606,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
606,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
607,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
607,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
608,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
608,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
608,3,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
609,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
610,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
610,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
610,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
611,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
612,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
613,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
614,1,Deafness,Hearing losses,Hearing disorders,Ear,N
615,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
616,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
616,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
617,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
617,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
618,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
619,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
620,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
621,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
621,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
622,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
623,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
623,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
623,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
623,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
623,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
623,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
623,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
623,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
624,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
624,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
624,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
624,4,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
625,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
626,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
627,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
628,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
628,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
628,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
629,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
629,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
630,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
631,1,Sarcoma metastatic,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
632,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
632,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
632,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
633,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
634,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
634,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
635,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
636,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
636,2,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
636,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
636,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
637,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
637,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
637,3,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
638,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
639,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
639,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
640,1,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
641,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
642,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
643,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
643,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
644,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
644,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
644,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
644,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
645,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
646,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
647,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
648,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
649,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
650,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
651,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
651,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
652,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
653,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
653,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
654,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
654,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
654,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
654,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
654,5,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
654,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
655,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
655,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
655,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
656,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
656,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
656,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
657,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
657,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
658,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
659,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
660,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
660,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
661,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
661,2,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
662,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
663,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
664,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
665,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
666,1,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
666,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
667,1,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
668,1,Large intestine infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
669,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
670,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
670,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
670,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
670,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
670,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
671,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
672,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
672,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
672,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
672,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
672,5,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
672,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
673,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
673,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
673,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
674,1,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
675,1,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
676,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
676,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
677,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
677,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
678,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
679,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
680,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
680,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
681,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
681,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
682,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
682,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
683,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
684,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
685,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
685,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
686,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
686,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
686,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
687,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
688,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
689,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
689,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
689,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
690,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
691,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
691,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
692,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
692,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
693,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
693,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
693,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
693,4,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
693,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
693,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
694,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
694,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
694,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
695,1,Acute left ventricular failure,Left ventricular failures,Heart failures,Card,N
696,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
697,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
698,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
699,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
700,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
701,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
702,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
702,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
702,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
703,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
704,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
704,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
704,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
705,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
705,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
706,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
706,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
707,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
708,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
708,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
709,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
709,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
710,1,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
710,2,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
710,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
711,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
711,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
711,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
711,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
712,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
712,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
712,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
713,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
713,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
713,3,Mediastinal mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
713,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
713,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
713,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
714,1,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
714,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
715,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
715,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
716,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
716,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
716,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
717,1,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
717,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
717,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
718,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
719,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
719,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
720,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
721,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
722,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
722,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
722,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
722,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
723,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
723,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
724,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
725,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
726,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
726,2,Erosive duodenitis,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
726,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
727,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
727,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
728,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
729,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
730,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
730,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
730,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
731,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
731,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
731,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
732,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
732,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
732,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
732,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
732,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
732,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
733,1,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,Y
733,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
734,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
734,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
735,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
736,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
736,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
736,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
736,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
736,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
736,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
737,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
737,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
737,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
737,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
737,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
738,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
739,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
739,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
739,3,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
739,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
739,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
740,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
740,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
740,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
741,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
741,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
742,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
742,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
742,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
743,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
743,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
744,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
744,2,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
744,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
744,4,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
744,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
744,6,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
744,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
744,8,Postural reflex impairment,Abnormal reflexes,Neurological disorders NEC,Nerv,N
744,9,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
745,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
745,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
746,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
746,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
746,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
746,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
746,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
746,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
746,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
746,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
747,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
747,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
748,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
749,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
750,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
751,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
751,2,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
751,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
752,1,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
753,1,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
754,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
754,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
754,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
754,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
755,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
755,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
756,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
756,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
757,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
757,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
758,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
758,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
759,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
759,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
760,1,Febrile infection,Infections NEC,Infections - pathogen unspecified,Infec,N
760,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
760,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
761,1,Cryoglobulins,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
761,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
761,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
761,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
761,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
761,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
762,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
762,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
762,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
762,4,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
762,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
762,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
763,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
763,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
763,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
764,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
765,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
766,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
766,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
767,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
767,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
767,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
768,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
768,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
769,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
770,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
771,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
771,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
771,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
772,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
773,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
774,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
775,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
776,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
777,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
778,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
779,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
780,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
781,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
781,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
781,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
782,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
783,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
783,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
783,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
784,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
784,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
784,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
785,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
785,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
785,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
786,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
786,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
786,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
786,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
786,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
787,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
788,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
789,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
790,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
790,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
790,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
790,4,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
790,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
790,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
790,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
790,8,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
790,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
790,10,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
791,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
792,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
792,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
793,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
793,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
794,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
795,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
796,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
796,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
796,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
797,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
797,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
798,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
799,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
799,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
800,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
800,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
800,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
801,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
801,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
801,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
802,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
802,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
802,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
803,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
803,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
804,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
805,1,Conjunctival irritation,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
806,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
806,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
806,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
806,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
806,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
806,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
806,7,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
807,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
807,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
807,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
807,4,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
807,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
807,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
807,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
808,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
808,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
808,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
809,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
810,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
810,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
811,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
811,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
811,3,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
812,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
812,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
813,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
813,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
813,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
813,4,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
814,1,Epiglottitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
814,2,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
814,3,Upper airway obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
815,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
816,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
816,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
816,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
817,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
817,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
817,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
817,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
817,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
818,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
819,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
820,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
820,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,Y
820,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
821,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
822,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
823,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
823,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
823,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
823,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
823,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
824,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
824,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
825,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
825,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
826,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
826,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
826,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
827,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
828,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
828,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
829,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
829,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
830,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
830,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
830,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
830,4,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
831,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
832,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
832,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
833,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
833,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
833,3,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
834,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
834,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
835,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
835,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
835,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
836,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
837,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
838,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
838,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
839,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
839,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
839,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
839,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
840,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
841,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
841,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
841,3,Hyperviscosity syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
841,4,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
841,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
842,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
842,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
842,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
842,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
843,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
843,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
843,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
844,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
844,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
844,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
845,1,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
846,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
847,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
847,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
847,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
848,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
849,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
849,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
849,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
850,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
850,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
851,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
852,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
853,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
853,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
853,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
853,4,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
853,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
853,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
854,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
855,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
855,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
855,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
856,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
857,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
857,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
857,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
857,4,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
858,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
859,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
859,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
859,3,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
859,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
860,1,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
861,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
861,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
861,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
861,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
862,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
862,2,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
863,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
863,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
864,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
864,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
864,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
864,4,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
865,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
866,1,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
867,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
868,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
868,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
869,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
870,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
871,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
872,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
873,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
873,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
873,3,Sternal fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
874,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
874,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
874,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
874,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
874,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
874,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
874,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
874,8,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
874,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
874,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
874,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
874,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
875,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
875,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
875,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
875,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
875,5,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
876,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
876,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
877,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
877,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
877,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
877,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
877,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
878,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
878,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
878,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
879,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
880,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
880,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
880,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
881,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
882,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
882,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
883,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
883,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
883,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
883,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
883,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
883,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
883,7,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
883,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
884,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
885,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
885,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
885,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
885,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
885,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
886,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
886,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
887,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
887,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
888,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
888,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
889,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
890,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
890,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
891,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
891,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
892,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
892,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
892,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
893,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
893,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
893,3,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
893,4,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
894,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
894,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
895,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
895,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
895,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
896,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
897,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
898,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
899,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
900,1,Chronic respiratory disease,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
900,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
901,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
901,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
902,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
902,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
902,3,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
902,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
903,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
903,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
903,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
904,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
904,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
905,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
905,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
906,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
906,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
906,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
906,4,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
907,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
908,1,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
908,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
909,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
910,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
911,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
912,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
912,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
912,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
912,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
913,1,Glucose tolerance test abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
913,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
913,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
914,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
915,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
915,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
915,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
915,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
916,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
916,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
917,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
918,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
918,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
919,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
919,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
920,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
921,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
922,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
923,1,Plasma cell leukaemia,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
923,2,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
923,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
924,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
924,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
924,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
925,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
925,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
926,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
927,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
927,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
928,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
929,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
929,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
930,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
931,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
931,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
931,3,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
931,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
932,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
933,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
933,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
934,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
934,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
934,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
935,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
935,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
936,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
936,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
936,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
936,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
936,5,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
936,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
936,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
937,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
938,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
938,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
939,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
940,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
940,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
940,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
941,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
941,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
941,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
942,1,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
943,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
943,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
944,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
944,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
944,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
944,4,Cardiac output decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
945,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
945,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
946,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
947,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
948,1,Deafness,Hearing losses,Hearing disorders,Ear,N
948,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
948,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
949,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
950,1,Sarcoma of skin,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
951,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
952,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
952,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
953,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
954,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
954,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
955,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
955,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
955,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
955,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
955,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
955,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
955,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
955,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
955,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
956,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
956,2,Hyperammonaemic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
956,3,Metabolic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
956,4,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
957,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
957,2,Humerus fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
958,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
958,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
958,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
958,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
958,5,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
958,6,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
958,7,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
958,8,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
958,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
958,10,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
958,11,Right atrial dilatation,Myocardial disorders NEC,Myocardial disorders,Card,N
959,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
959,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
960,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
960,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
961,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
961,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
962,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
962,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
963,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
964,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
964,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
964,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
965,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
965,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
966,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
967,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
968,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
969,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
970,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
970,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
971,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
971,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
972,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
972,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
972,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
973,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
973,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
973,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
973,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
974,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
974,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
975,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
975,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
975,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
976,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
976,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
976,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
977,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
977,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
978,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
978,2,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
978,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
978,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
978,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
978,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
978,7,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
978,8,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
979,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
979,2,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
979,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
979,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
979,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
979,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
979,7,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
979,8,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
980,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
980,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
981,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
982,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
983,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
984,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
985,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
986,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
987,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
988,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
989,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
990,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
990,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
991,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
991,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
992,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
993,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
994,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
994,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
994,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
994,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
994,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
994,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
995,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
996,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
996,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
996,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
997,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
998,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
999,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
1000,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
1001,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1001,2,Respiratory syncytial virus bronchiolitis,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1002,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1002,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1002,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1002,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1002,5,Duodenal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1002,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1002,7,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1002,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1002,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1002,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1003,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1004,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1005,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1005,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1006,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1007,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1007,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1007,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1008,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1008,2,Disorder of orbit,Ocular disorders NEC,Eye disorders NEC,Eye,N
1009,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1010,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1011,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1012,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1013,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1014,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1015,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1016,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1017,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1018,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1019,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1020,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1021,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1022,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1023,1,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1023,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1023,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1023,4,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1023,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1023,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1024,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1024,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1025,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1025,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1026,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1027,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1028,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1028,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1029,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1029,2,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1030,1,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1031,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1031,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1031,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1031,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1031,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1031,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1031,7,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1031,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1031,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1031,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1031,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1031,12,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1031,13,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1032,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1033,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1033,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1034,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1034,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1034,3,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1034,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1034,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1034,6,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1035,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1035,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1036,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1036,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1036,3,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,Y
1036,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1036,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1036,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1037,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1037,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1037,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1038,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1039,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1040,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1040,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1041,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1041,2,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1042,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1043,1,Metastases to skin,Metastases to specified sites,Metastases,Neopl,Y
1044,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1045,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1046,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1046,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1047,1,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1047,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1047,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1047,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1048,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1049,1,Autoimmune neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1050,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1050,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1050,3,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
1050,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1051,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1051,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1051,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1052,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1053,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1053,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1054,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1055,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1055,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
1055,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1056,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1057,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1057,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1058,1,Acquired haemophilia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1058,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1059,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1059,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1060,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1060,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1061,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1062,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1062,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1063,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1063,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1064,1,Headache,Headaches NEC,Headaches,Nerv,N
1064,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1064,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1064,4,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1065,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1065,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1065,3,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1066,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1066,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1067,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1067,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1067,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1067,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1067,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1067,6,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1068,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1069,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1069,2,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
1069,3,Headache,Headaches NEC,Headaches,Nerv,N
1069,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1070,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1071,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1072,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1073,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
1073,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1073,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1074,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1074,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1075,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1075,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1075,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1076,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1076,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1076,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1077,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1077,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1077,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1077,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1077,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1077,6,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1077,7,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1078,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1078,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1079,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1080,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1081,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1081,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1081,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1082,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1083,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1083,2,Plasma cell leukaemia,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1083,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1084,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1084,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1084,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1084,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1085,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1085,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1085,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1085,4,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1085,5,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1085,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1085,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1085,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1085,9,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1085,10,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1085,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1085,12,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1085,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1085,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1085,15,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1086,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1086,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1086,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1086,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1086,5,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1087,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1087,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1087,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1088,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1089,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1089,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1089,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1090,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1091,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1091,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1091,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1092,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1092,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1093,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1093,2,Blast cell count increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1093,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1093,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1093,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1094,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1095,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1095,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1095,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1095,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1095,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1095,6,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1096,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1097,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1097,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1097,3,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1097,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1097,5,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1098,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1098,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1098,3,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1098,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1099,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1099,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1099,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1099,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1100,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1100,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1101,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1102,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1102,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1102,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1102,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1102,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1102,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1102,7,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1102,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1102,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1102,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1102,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1102,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1103,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1103,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1104,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1104,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1104,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1104,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1104,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1105,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1105,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1105,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1105,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1106,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1107,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1108,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1108,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1109,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1109,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1109,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1110,1,Altered visual depth perception,Refractive and accommodative disorders,Vision disorders,Eye,N
1110,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1110,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1110,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1110,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1110,6,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1110,7,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1110,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1110,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1110,10,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1111,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1112,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1112,2,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1112,3,Product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1112,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1112,5,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1113,1,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1113,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,Y
1113,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1113,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1113,5,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1114,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1114,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1115,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1115,2,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1115,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1115,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1115,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1115,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1115,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1115,8,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1115,9,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1116,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1116,2,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1116,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1116,4,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1116,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1116,6,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1116,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1116,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1116,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1116,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1116,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1116,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1116,13,Spinal stenosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1116,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1116,15,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1117,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1117,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1118,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1119,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1120,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1120,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1120,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1121,1,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1122,1,Exposed bone in jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1122,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1123,1,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1123,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1124,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1124,2,Huntington's disease,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,Y
1125,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1125,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1125,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1125,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1126,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1127,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1127,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1128,1,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1128,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1128,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1128,4,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1128,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1129,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1130,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1131,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1131,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1132,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1132,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1132,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1132,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1132,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1132,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1133,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1133,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1134,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1134,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1134,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1135,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1135,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1135,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1135,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1135,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1135,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1135,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1136,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1136,2,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1136,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1137,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1137,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1137,3,Hypoproteinaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1137,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1137,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1137,6,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1138,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1138,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1138,3,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1138,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1138,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1138,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1138,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1138,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1138,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1138,10,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1138,11,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1138,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1138,13,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1138,14,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1138,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1139,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1139,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1139,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1139,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1139,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1140,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1141,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1141,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1141,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1141,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1141,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1142,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1142,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1142,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1142,4,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1142,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1142,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1142,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1142,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1142,9,Prostatic obstruction,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
1142,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1143,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1144,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1145,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1145,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1145,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1146,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1147,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1148,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1149,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1149,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1149,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1149,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1150,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1150,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1151,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1152,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1152,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1152,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1152,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1152,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1152,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1152,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1152,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1153,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1153,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1154,1,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1154,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1154,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1155,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1155,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1155,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1155,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1156,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1156,2,Mantle cell lymphoma refractory,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1157,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1158,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1158,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1158,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1158,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1159,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1160,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1160,2,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
1160,3,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1160,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1160,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1161,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1161,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1161,3,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1162,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1163,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1163,2,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1163,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1163,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1164,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1164,2,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1164,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1164,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1165,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1165,2,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1165,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1165,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1166,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1166,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1167,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1167,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1167,3,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1167,4,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1167,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1167,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1167,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1167,8,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1167,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1167,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1167,11,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1167,12,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1167,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1167,14,Headache,Headaches NEC,Headaches,Nerv,N
1167,15,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1167,16,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1167,17,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1167,18,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1167,19,Myalgia,Muscle pains,Muscle disorders,Musc,N
1167,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1167,21,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1167,22,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1167,23,Respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
1167,24,Synovial cyst,Synovial disorders,Synovial and bursal disorders,Musc,N
1167,25,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1167,26,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1167,27,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1167,28,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1168,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1168,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1169,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1169,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1169,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1170,1,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
1171,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1171,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1172,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1172,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1173,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1174,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1174,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1174,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1175,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1175,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1175,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1176,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1176,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1176,3,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1176,4,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1177,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1177,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1178,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1180,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1180,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1180,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1180,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1180,5,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1180,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1181,1,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1182,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1182,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1182,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1182,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1182,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1182,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1183,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1184,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1184,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1185,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1186,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1186,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1186,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1186,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1187,1,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1188,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1189,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1190,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1190,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1191,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1191,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1192,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1193,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1194,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1195,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1196,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1196,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1197,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,Y
1197,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1197,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1197,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1197,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1198,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1198,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1199,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1199,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1200,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1200,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1201,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1202,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1203,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1204,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1205,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1205,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1205,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1205,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1205,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1205,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1206,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1206,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1207,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1208,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1209,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1209,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1210,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1210,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1210,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1211,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1212,1,Myelodysplastic syndrome with multilineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,N
1212,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1213,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1213,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1213,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1213,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1213,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1213,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1214,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1215,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1216,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1217,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1217,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1217,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1217,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1218,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1219,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1219,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1219,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1219,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1219,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1220,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1221,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,Y
1222,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1223,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1224,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
1225,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1225,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1225,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1225,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1225,5,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1226,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1226,2,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1226,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1226,4,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1227,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1228,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1228,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1228,3,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1229,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1230,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1230,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1231,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1232,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1232,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1232,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1232,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1232,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1232,6,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1232,7,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1232,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1232,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1232,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1232,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1233,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1233,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1233,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1234,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1235,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1236,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1237,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1237,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1237,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1237,4,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1237,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1238,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1239,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1240,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1240,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1240,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1241,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1242,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1243,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1244,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1244,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1245,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1245,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1246,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1246,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1246,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1247,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1247,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1248,1,Arteriovenous fistula thrombosis,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1248,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1248,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1249,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1249,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1249,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1249,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1250,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1251,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1252,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1253,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1253,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1254,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1254,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1255,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1255,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1256,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1256,2,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1256,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1256,4,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1256,5,Oral blood blister,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1256,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1257,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1257,2,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,Y
1257,3,Headache,Headaches NEC,Headaches,Nerv,N
1257,4,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1257,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1258,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1258,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1259,1,Headache,Headaches NEC,Headaches,Nerv,N
1259,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1259,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1259,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1260,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1260,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1260,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1261,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1262,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1262,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1263,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1264,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1264,2,Headache,Headaches NEC,Headaches,Nerv,N
1264,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1264,4,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1265,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1266,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1266,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1267,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1268,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1269,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1269,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1269,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1270,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1270,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1271,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1271,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1271,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1272,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1272,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1272,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1272,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1272,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1272,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1272,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1272,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1272,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1272,10,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1272,11,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1272,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1272,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1272,14,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1272,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1273,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1274,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1274,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1274,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1274,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1274,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1274,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1274,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1274,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1274,9,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1275,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1275,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1275,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1276,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1277,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1277,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1277,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1277,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1277,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1278,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1278,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1278,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1279,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1279,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1280,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1280,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1281,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1281,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1281,3,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1281,4,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1281,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1282,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1282,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1283,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1283,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1283,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1284,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1284,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1284,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1285,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1286,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1286,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1287,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1287,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1287,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1288,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1288,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1289,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1290,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1291,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1291,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1291,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1291,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1291,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1291,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1291,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1291,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1291,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1292,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1292,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1293,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1293,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1294,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1294,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1295,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1295,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1295,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1295,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1295,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1295,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1295,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1295,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1295,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1296,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1296,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1296,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1296,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1296,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1297,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1297,2,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1297,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1298,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1299,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1299,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1299,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1300,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1301,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1302,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1302,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1302,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1303,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1303,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1304,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1304,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1305,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1305,2,Headache,Headaches NEC,Headaches,Nerv,N
1305,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1306,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1306,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1306,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1307,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1307,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1307,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1307,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1307,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1307,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1308,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1309,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1310,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1311,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1312,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1313,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1313,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1313,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1313,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1314,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1314,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1315,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1315,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1315,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1316,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1316,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1317,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1318,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1319,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1319,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1320,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1320,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1320,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1321,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1322,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1323,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1323,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1324,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1324,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1325,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1325,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1325,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1326,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1327,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1328,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1329,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1329,2,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1329,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1329,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1329,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1329,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
1329,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1329,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1330,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1331,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1331,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1331,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1331,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1332,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1333,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1334,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1335,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1336,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1336,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1336,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1336,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1337,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1337,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1337,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1338,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1339,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1339,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1339,3,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
1340,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1341,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1342,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1342,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1343,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1344,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1344,2,Headache,Headaches NEC,Headaches,Nerv,N
1344,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1344,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1345,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1346,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1346,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1346,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1346,4,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1346,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1347,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1348,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1349,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1349,2,Obstruction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1349,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1350,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1351,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
1351,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1352,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1352,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1352,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1352,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1353,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1354,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1354,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1355,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1355,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1355,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1355,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1356,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1356,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1357,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1357,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1357,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1357,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1358,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1359,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
1360,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1361,1,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1361,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1362,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1363,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1364,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1365,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1366,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1367,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1367,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1367,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1368,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1369,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1369,2,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1369,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1370,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1371,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1372,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1373,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1374,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1374,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1374,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1375,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1376,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1376,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1377,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1377,2,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1377,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1377,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
1377,5,Fungal test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
1377,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1377,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1377,8,Respirovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1378,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1379,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1379,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1379,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1380,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1381,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1382,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1382,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1383,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1384,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1385,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1386,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1386,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1386,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1387,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1387,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1388,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1388,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1388,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1389,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1389,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1389,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1390,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1390,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1390,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1391,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1392,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1392,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1392,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1393,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1394,1,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1395,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1395,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1396,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1397,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1398,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1399,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1400,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1401,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1402,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1403,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1403,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1403,3,Waldenstrom's macroglobulinaemia,Waldenstrom's macroglobulinaemias,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1404,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1404,2,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
1405,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1405,2,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1406,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1406,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1407,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1407,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1408,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1408,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1408,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1409,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1409,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1410,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
1411,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1412,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1412,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1413,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1414,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1415,1,Chalazion,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1416,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1416,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1416,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1416,4,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1417,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1417,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1417,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1418,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1419,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1419,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1419,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1420,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1420,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1421,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1421,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1422,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1422,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1422,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1422,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1422,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1422,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1423,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1423,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1423,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1423,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1423,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1423,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1424,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1424,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1425,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1425,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1425,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1426,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1426,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1426,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1426,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1426,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1426,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1426,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1427,1,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1428,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1428,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1428,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1428,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1429,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1429,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1430,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1430,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1431,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1432,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1433,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1434,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1434,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1434,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1435,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1435,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1435,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1435,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1435,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1436,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1436,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1437,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1437,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1438,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1438,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1439,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1439,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1439,3,Oroantral fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1439,4,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1439,5,Periodontal disease,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1439,6,Periodontitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1439,7,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1439,8,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1439,9,Tooth deposit,Dental surface disorders,Dental and gingival conditions,Gastr,N
1440,1,Chronic sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1440,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1440,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1440,4,Oroantral fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1440,5,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1440,6,Periodontitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1440,7,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1441,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1442,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1442,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1443,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1444,1,Pneumonia influenzal,Influenza viral infections,Viral infectious disorders,Infec,N
1444,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1445,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1446,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1446,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1446,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1447,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1447,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1447,3,Plasma cell leukaemia,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1448,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1448,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1448,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1448,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1449,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1450,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1451,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1451,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1451,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1451,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1451,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1451,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1452,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1453,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
1454,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1454,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1455,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1455,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1456,1,Cold type haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1456,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1456,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1456,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1456,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1457,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1458,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1459,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1460,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1461,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1462,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1463,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1464,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1464,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1464,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1465,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1465,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1465,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1466,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1466,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1466,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1467,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1468,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1468,2,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
1469,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1470,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1470,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1471,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1471,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1472,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1473,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1474,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1474,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1474,3,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1475,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1476,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1477,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1477,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1477,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1477,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1477,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1477,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1477,7,Food aversion,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1477,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1477,9,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1477,10,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1477,11,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1477,12,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1477,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1477,14,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1477,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1477,16,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
1477,17,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1477,18,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1478,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1479,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1480,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1480,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1481,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1482,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1483,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1484,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1485,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1486,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
1487,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1487,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1487,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1487,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1488,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1488,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1488,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1489,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1489,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1489,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1490,1,Plasma cell myeloma refractory,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1491,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1491,2,Self-medication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1492,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1493,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1494,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1494,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
1494,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1494,4,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
1495,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1496,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1496,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1496,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1497,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1497,2,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1497,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1498,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1498,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1499,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1499,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1499,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1500,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1501,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1502,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1502,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1503,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1503,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1503,3,Therapeutic product effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1504,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1505,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1506,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1507,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1508,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1508,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1509,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1510,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1511,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1511,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1512,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1512,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1512,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1513,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1513,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1513,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1514,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1514,2,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1514,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1514,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1515,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1515,2,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1515,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1515,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1516,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1516,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1517,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1517,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1517,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1517,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1518,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1518,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1519,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1520,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1520,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1520,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1521,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1521,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1521,3,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1521,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1521,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1522,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1522,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1522,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1522,4,Therapeutic product effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1523,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1523,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1523,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1523,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1523,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1523,6,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1523,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1523,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1523,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1523,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1524,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1524,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1524,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1525,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1525,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1526,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1527,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1528,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1529,1,Pericarditis constrictive,Noninfectious pericarditis,Pericardial disorders,Card,N
1530,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1530,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1530,3,Joint warmth,Joint related signs and symptoms,Joint disorders,Musc,N
1531,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1532,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1532,2,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1532,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1532,4,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1532,5,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1532,6,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1532,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1532,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1532,9,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1532,10,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1532,11,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1532,12,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1532,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1532,14,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1532,15,Intentional device misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1532,16,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1532,17,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1532,18,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1532,19,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1532,20,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1532,21,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1533,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1534,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1535,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1536,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1536,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1536,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1537,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1537,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1537,3,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1537,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1537,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1538,1,Thyrotoxic crisis,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,Y
1539,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1539,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1539,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1540,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1540,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1540,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1540,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1541,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1541,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1542,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1543,1,Blood osmolarity decreased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
1543,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
1543,3,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1543,4,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1543,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1543,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1543,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1543,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1543,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1544,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1544,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1544,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1545,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1546,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1546,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1547,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1547,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1548,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1549,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1549,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1550,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1551,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1551,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1552,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1552,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1552,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1552,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1552,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1552,6,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1552,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1552,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1552,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1552,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1552,11,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1552,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1553,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1554,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
1555,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1556,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1557,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1557,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1557,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1557,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1558,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1559,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1559,2,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
1559,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1560,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
1560,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1561,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1562,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1563,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1563,2,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
1563,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1563,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1564,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1565,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1566,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1566,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1567,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1567,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1567,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1567,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1568,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1569,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1569,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1569,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1569,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1570,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1571,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1572,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1573,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1574,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1575,1,Musculoskeletal toxicity,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1575,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1576,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1577,1,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1577,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1578,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1578,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1578,3,Myositis-like syndrome,Muscle infections and inflammations,Muscle disorders,Musc,N
1578,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1578,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1579,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1580,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1581,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1582,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1582,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1582,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1582,4,N-terminal prohormone brain natriuretic peptide decreased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1582,5,N-terminal prohormone brain natriuretic peptide increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1582,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1582,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1582,8,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1582,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1583,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1583,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1584,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1585,1,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1586,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1587,1,Autoimmune myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1587,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1588,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1589,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1590,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1591,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1592,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1593,1,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
1594,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1595,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1595,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1595,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1596,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1596,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1597,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1598,1,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
1599,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1600,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1600,2,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1600,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1600,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1600,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1600,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1600,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1601,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1602,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1603,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1603,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1603,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1604,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1605,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1606,1,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1607,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1608,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1608,2,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1608,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1608,4,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1608,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1608,6,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
1608,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1608,8,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1609,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1610,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1610,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1611,1,Plasma cell myeloma refractory,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1612,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1612,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1613,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1613,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1614,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1615,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1616,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1617,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1618,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1619,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1620,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1620,2,Pseudomyopia,Refractive and accommodative disorders,Vision disorders,Eye,N
1621,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1622,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1622,2,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1623,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1623,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1623,3,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1624,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1625,1,Cardiac amyloidosis,Cardiomyopathies,Myocardial disorders,Card,Y
1625,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1625,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1626,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
1626,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1626,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1626,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1626,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1626,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1626,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1627,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
1628,1,Headache,Headaches NEC,Headaches,Nerv,N
1629,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1630,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1630,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1631,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1632,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1633,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1633,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1634,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1634,2,Laboratory test interference,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1635,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1635,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1635,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1636,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1637,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1637,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1637,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1637,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1637,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1638,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1638,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1638,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1638,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1638,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1638,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1638,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1638,8,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1638,9,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1638,10,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1638,11,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1638,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1638,13,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1638,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1639,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1639,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1639,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1640,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1641,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1642,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1642,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1642,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1642,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1642,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1642,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1643,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1644,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1645,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1646,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1646,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1647,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1647,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1647,3,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
1648,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1648,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1649,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1649,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1649,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1649,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1650,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1651,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1652,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1653,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1654,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1655,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1655,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1655,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1655,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1656,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1656,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1656,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1656,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1656,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1656,6,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1656,7,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1656,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1656,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1656,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1656,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1656,12,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1656,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1656,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1656,15,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1656,16,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1656,17,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1656,18,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1657,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1658,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1658,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1658,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1659,1,Red blood cell agglutination,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1660,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1661,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1662,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1663,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1663,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1663,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1663,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1663,5,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1663,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1663,7,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1663,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1663,9,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1663,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1663,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1663,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1663,13,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1663,14,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1663,15,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1663,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1664,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1664,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1664,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1664,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1664,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1665,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1665,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1665,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1665,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1665,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1666,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1666,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1667,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1668,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1668,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1668,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1669,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1670,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1671,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1672,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1673,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1673,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1674,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1675,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1676,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1677,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1677,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1677,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1677,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1677,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1677,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1677,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1678,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1678,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1678,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1678,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1678,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1679,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1680,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1681,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1681,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1682,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1683,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1684,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1684,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1684,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1685,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1685,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1685,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1686,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1686,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1687,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1688,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1688,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1688,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1689,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1689,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1690,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1691,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1691,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1691,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1691,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1691,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1692,1,Aspiration bone marrow,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
1692,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1692,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1692,4,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1693,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1693,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1693,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1694,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1695,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1695,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1695,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1695,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1695,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1696,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1696,2,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1697,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1698,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1698,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1699,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1699,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1700,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1700,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1701,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1702,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1703,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1703,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1703,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1703,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1703,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1703,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1704,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1705,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1706,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1707,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1707,2,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1708,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1709,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1710,1,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
